New Coronavirus Variant Sweeping Through New York City
THURSDAY, Feb. 25, 2021 -- A new coronavirus variant that is sweeping through New York City has a mutation that may weaken the effectiveness of vaccines, two new studies claim.
The new variant is called B.1.526 and was first detected in samples gathered in the city in November. By the middle of February, it accounted for about one-quarter of viral sequences appearing in a database used by scientists, The New York Times reported.
One study was conducted at Columbia University and the other was led by a group at Caltech. The Columbia study has not been made public, but the Caltech study was posted online Tuesday. Neither study has been peer-reviewed or published in a scientific journal.
"It's not particularly happy news," Michel Nussenzweig, M.D., an immunologist at Rockefeller University, told The Times. "But just knowing about it is good because then we can perhaps do something about it." Nussenzweig, who was not involved in the new studies, said he is more concerned about the variant in New York than the one that is rapidly spreading in California.
Another variant that was originally identified in Britain is expected to become the most common form of the coronavirus in the United States by the end of March, The Times reported.
© 2021 HealthDay. All rights reserved.
Posted: February 2021
Further Support and Information on COVID-19
Read this next
WEDNESDAY, April 21, 2021 -- Improper disinfection and not following contamination prevention protocols are among the nine violations found by U.S. Food and Drug Administration...
WEDNESDAY, April 21, 2021 -- Since the first COVID-19 vaccine was approved in December, millions of Americans have eagerly sought to find and receive one. But a new report reveals...
WEDNESDAY, April 21, 2021 -- In high-income and upper-middle-income countries, suicide numbers remained unchanged or declined in the early months of the pandemic versus the...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.